V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10473752 | 10070704 | 1.7 | 67.4 | null | 2021-11-02 | 2021-11-15 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100670961 |
| 10473764 | 10070705 | 1.71 | 45.8 | null | 2021-05-05 | 2021-05-23 | Avelumab | 02 | null | VENETOCLAX | 101832249 |
| 10474351 | 10070707 | 1.58 | 61 | null | 2022-02-11 | 2022-03-06 | Avelumab | 02 | null | VENETOCLAX | 101170230 |
| 10474442 | 10070708 | 1.82 | 64.1 | null | 2020-01-20 | 2020-02-02 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100929797 |
| 10474494 | 10070709 | 1.58 | 64.8 | Palliative (P) | 2022-05-17 | 2022-05-30 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101726840 |
| 10474605 | 10070710 | 1.83 | 105 | null | null | 2017-07-29 | Avelumab | 02 | null | DARATUMUMAB | 101406012 |
| 10474775 | 10070711 | 1.72 | 79.7 | Palliative (P) | null | 2019-09-16 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100544205 |
| 10474868 | 10070712 | 1.76 | 66.7 | null | 2022-03-14 | 2022-04-06 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 100326769 |
| 10474959 | 10070713 | 1.57 | 72.6 | Palliative (P) | 2020-02-18 | 2020-03-03 | Avelumab | 02 | N | TRASTUZUMAB | 100133294 |
| 10475006 | 10070715 | 1.57 | 80.5 | Palliative (P) | 2021-03-12 | 2021-03-12 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100529686 |
| 10475414 | 10070717 | 0 | 74 | Adjuvant (A) | null | 2021-07-20 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 101679561 |
| 10475655 | 10070718 | 1.69 | 56.2 | Adjuvant (A) | null | 2020-08-05 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100819021 |
| 10475839 | 10070719 | 1.81 | 108.8 | Palliative (P) | 2019-11-26 | 2019-12-03 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101566247 |
| 10476007 | 10070720 | 1.58 | 62.3 | Palliative (P) | null | 2021-04-23 | Avelumab | 99 | N | FLUOROURACIL + OXALIPLATIN | 101783671 |
| 10476167 | 10070721 | 1.5 | 69.1 | null | null | 2018-05-23 | RUXOLITINIB | 02 | null | DARATUMUMAB | 101822073 |
| 10476208 | 10070722 | 1.88 | 86.25 | null | null | 2021-01-31 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 101219215 |
| 10476349 | 10070723 | 1.62 | 50.3 | null | 2021-05-08 | 2021-05-18 | Avelumab | 02 | N | AVELUMAB | 100795698 |
| 10476432 | 10070724 | 1.56 | null | null | 2018-01-01 | 2019-11-11 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100941545 |
| 10476870 | 10070725 | 1.82 | 68.9 | null | 2022-02-26 | 2022-02-26 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101542939 |
| 10476979 | 10070726 | 1.67 | 71.2 | Palliative (P) | 2019-10-21 | 2020-04-01 | Venetoclax | 02 | null | VENETOCLAX | 100546780 |
| 10477000 | 10070727 | 1.83 | 80.1 | Adjuvant (A) | 2020-06-27 | 2020-07-14 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100559763 |
| 10477284 | 10070729 | 1.59 | 76.1 | Palliative (P) | 2015-01-24 | 2019-01-04 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100779797 |
| 10477406 | 10070730 | 1.54 | 70.7 | null | 2022-02-23 | 2022-05-27 | DARATUMUMAB | null | null | DARATUMUMAB | 100486177 |
| 10477780 | 10070731 | 1.83 | 102.5 | null | 2019-05-10 | 2019-05-18 | GEMCARBO | 2 | null | CARBOPLATIN + GEMCITABINE | 101618022 |
| 10478018 | 10070733 | 1.66 | 54.2 | Neo-adjuvant (N) | 2020-04-03 | 2020-07-01 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101065849 |
| 10478223 | 10070734 | null | 76 | 03 | 2020-08-27 | 2020-08-27 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100055196 |
| 10478241 | 10070735 | 1.71 | 86.4 | null | 2021-12-06 | 2021-12-06 | Venetoclax | 02 | null | VENETOCLAX | 100094916 |
| 10478666 | 10070738 | 1.67 | 64.7 | null | null | 2020-04-21 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100445526 |
| 10478886 | 10070739 | 1.61 | 66.8 | Adjuvant (A) | 2017-08-04 | 2017-08-05 | Bendamustine+Rituximab (1st Course) | N | N | BENDAMUSTINE + RITUXIMAB | 100964971 |
| 10478991 | 10070740 | 1.61 | null | null | 2020-03-18 | 2020-04-13 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100486701 |
| 10479274 | 10070742 | 1.61 | 76 | null | 2020-11-27 | 2021-01-10 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101274669 |
| 10479358 | 10070743 | 1.57 | 78 | Palliative (P) | 2017-06-12 | 2018-02-05 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100276862 |
| 10479543 | 10070744 | 1.75 | null | Palliative (P) | 2019-04-25 | 2019-05-13 | NIVOLUMAB | null | N | NIVOLUMAB | 100512914 |
| 10479792 | 10070745 | null | 45.8 | Adjuvant (A) | 2022-01-08 | 2022-01-12 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100215686 |
| 10479827 | 10070746 | 1.67 | 88.4 | null | 2022-03-04 | 2022-03-10 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101459334 |
| 10480215 | 10070748 | 1.61 | 76.9 | Adjuvant (A) | 2021-03-10 | 2021-03-23 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 100454175 |
| 10480411 | 10070749 | 1.69 | null | null | 2020-09-17 | 2020-11-09 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101360197 |
| 10480527 | 10070750 | 1.58 | 70 | Disease modification (D) | 2020-11-11 | 2021-08-02 | Venetoclax | 02 | N | VENETOCLAX | 100957815 |
| 10480584 | 10070751 | 1.63 | 68.3 | null | 2021-11-10 | 2021-11-24 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 100826685 |
| 10480656 | 10070753 | null | 71.8 | Palliative (P) | 2019-06-21 | 2019-07-14 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100881397 |
| 10480685 | 10070754 | 1.71 | 65.5 | 03 | null | 2018-05-01 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101028572 |
| 10480829 | 10070755 | 1.61 | 73 | Adjuvant (A) | 2022-03-03 | 2022-03-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100092207 |
| 10480995 | 10070756 | 1.85 | 81 | null | 2021-05-20 | 2021-06-03 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101534738 |
| 10481125 | 10070757 | 1.63 | 85.1 | Adjuvant (A) | 2022-02-17 | 2022-03-03 | Venetoclax | 02 | N | VENETOCLAX | 100572122 |
| 10481225 | 10070758 | null | 98.9 | Palliative (P) | 2022-02-21 | 2022-03-15 | Venetoclax | 02 | N | VENETOCLAX | 101223151 |
| 10481308 | 10070759 | 1.66 | 68.7 | Palliative (P) | 2019-12-07 | 2019-12-29 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101289950 |
| 10481992 | 10070761 | 1.59 | 57.6 | Palliative (P) | 2019-09-03 | 2019-09-17 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 100947385 |
| 10001985 | 10070763 | 1.53 | 91.4 | Palliative (P) | 2017-06-30 | 2018-01-28 | Venetoclax | 02 | N | VENETOCLAX | 101801414 |
| 10003300 | 10070764 | 1.77 | null | 03 | 2021-09-14 | 2021-09-15 | CEMIPLIMAB | N | N | CEMIPLIMAB | 101550335 |
| 10017166 | 10070766 | 1.68 | 85.2 | Palliative (P) | null | 2019-11-10 | Avelumab | 02 | N | NIVOLUMAB | 100287119 |